首页> 外文期刊>Chemotherapy: International Journal of Experimental and Clinical Chemotherapy >Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients.
【24h】

Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients.

机译:苯扎氯铵浸渍的中央静脉导管在预防癌症患者中预防导管相关感染的功效。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: This study was performed to determine the efficacy of a benzalkonium chloride-impregnated central venous catheter (CVC) in preventing catheter-related infection in patients suffering from malignant diseases and undergoing chemotherapy. METHODS: A randomized, prospective clinical trial was carried out to compare the incidence of catheter-related colonization and catheter-related bacteremia using an antiseptic-impregnated CVC (n = 25) with that using a standard triple-lumen CVC (n = 25). RESULTS: All patients were treated with intensive chemotherapy for acute leukemia (n = 28), lymphoma (n = 17) or solid tumors (n = 5). Both study groups presented with similar data in regards to age, insertion site, duration of catheterization and neutropenia period during catheterization, demonstrating a comparable risk for catheter-related colonization. Suspicion of infection led to explantation in 14 versus 15 cases. Catheter-related colonization was proven in 4 cases (16%) and catheter-related bacteremia was observed only once (4%) in both groups. Statistical testing showed no significant differences between the study and control group. CONCLUSIONS: The rate of catheter-related colonization was lower than suspected in this high-risk patient group. The use of benzalkonium chloride-impregnated CVC failed to decrease the incidence of catheter-related colonization and bacteremia in patients with a high risk of infectious complications. Copyright 1999 S. Karger AG, Basel
机译:背景:进行这项研究,以确定苯扎氯铵浸渍的中央静脉导管(CVC)预防恶性疾病和正在接受化疗的患者的导管相关感染的功效。方法:进行了一项随机,前瞻性的临床试验,比较了使用消毒浸渍的CVC(n = 25)和使用标准三腔CVC(n = 25)的导管相关定植和导管相关菌血症的发生率。 。结果:所有患者均接受了针对急性白血病(n = 28),淋巴瘤(n = 17)或实体瘤(n = 5)的强化化疗。两个研究组在年龄,插入部位,导管插入的持续时间和导管插入过程中的中性粒细胞减少期方面均提供了相似的数据,证明导管相关定植的风险相当。怀疑感染导致14例和15例外植。两组均证实导管相关的定植4例(16%),导管相关菌血症仅观察到一次(4%)。统计测试表明,研究组与对照组之间无显着差异。结论:与导管相关的定植率低于该高危患者组的怀疑率。在感染并发症风险高的患者中,使用苯扎氯铵浸渍的CVC不能降低导管相关的定植和菌血症的发生率。版权所有1999 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号